Patent · US Active

Fused bicyclic mTOR inhibitors

US8796455B2 · kind B2 · utility

6Cited by
10References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 15, 2013
Grant dateAug 5, 2014
Priority date—
Expiry dateFeb 15, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds represented by Formula (I)or a pharmaceutically acceptable salt thereof, are inhibitors of mTOR and useful in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.